Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-28
2011-06-28
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S266200, C514S252170, C544S116000, C544S284000
Reexamination Certificate
active
07968545
ABSTRACT:
The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
REFERENCES:
patent: 3248395 (1966-04-01), Ohnacker et al.
patent: 3311623 (1967-03-01), Ohnacker et al.
patent: 3316257 (1967-04-01), Ohnacker et al.
patent: 3346452 (1967-10-01), Carney et al.
patent: 3873530 (1975-03-01), Viehe et al.
patent: 4824846 (1989-04-01), Kampe et al.
patent: 4886807 (1989-12-01), Kitamura et al.
patent: 5250530 (1993-10-01), Giencke et al.
patent: 5972946 (1999-10-01), Murata et al.
patent: 6372740 (2002-04-01), Murata et al.
patent: 6627628 (2003-09-01), Schindler et al.
patent: 7091343 (2006-08-01), Bebbington et al.
patent: 7179826 (2007-02-01), Bebbington et al.
patent: 7223766 (2007-05-01), Dugar et al.
patent: 2004/0009981 (2004-01-01), Bebbington et al.
patent: 022481 (1981-01-01), None
patent: 0 276 057 (1988-07-01), None
patent: 2 450 (1964-04-01), None
patent: 1 455 810 (1966-09-01), None
patent: 1 048 986 (1966-11-01), None
patent: 04 224580 (1992-08-01), None
patent: 07 228573 (1995-08-01), None
patent: 11171865 (1999-06-01), None
patent: WO 9632383 (1996-10-01), None
patent: WO 0046214 (2000-08-01), None
patent: WO 0222601 (2002-03-01), None
patent: WO 0222602 (2002-03-01), None
patent: WO 0222604 (2002-03-01), None
patent: WO 03/037900 (2003-05-01), None
patent: WO 03/049739 (2003-06-01), None
Albrecht, et al., Europ. J. Med. Chem. (1976), 11(2), 155-8.
Shirakawa, et al., Takeda Kenkyusho Nenpo (1963), 22, 27-46.
Huenig, et al., Chemische Berichte (1962), 95, 937-43.
E. Arranz, et al., “Synthesis and Pharmacological Evaluation of 2,3-dihydro-3-oxo-4H-thieno[3,4-e][1,2,4]thiadiazine 1,1-dioxides as Voltage-Dependent Calcium Channel Blockers”,Eur. J. Med. Chem., 35: 751-759 (2000).
S. Ohno, et al., “Synthesis and Hypoglycemic Activity of 7, 8-Dihydro-6H-thiopyrano[3,2-d]pyrimidine Derivatives and Related Compounds”,Chem. Pharm. Bull, 34: 4150-4165 (1986).
A. Pastor et al., “Synthesis and Structure of New Pyrido [2,3-d] pyrimidine Derivatives with Calcium Channel Antagonist Activity”,Tetrahedron, 50: 8085-8098 (1994).
Database Beilstein ‘Online!’, Beilstein Institute for Organic Chemistry, Frankfurt-Main, DE; Database Accession No. 6927325 (BRN); XP002305900; 4-amino-2-phenyl-5,6,7,8-tetrahydroquinazoline-5-one; V.A. Dorokhov, et al.,Izv. Akad. Nauk. SSSR Ser. Khim., 8: 1504-1505 (1993).
Database Beilstein ‘Online!’, Beilstein Institute for Organic Chemistry, Frankfurt-Main, DE; Database Accession No. 76781-45-8 (CAS-RN); XP002305901; 2-piperazin-1-yl-6,7,8,9-tetrahydro-5H-cycloheptapyrimidin-4-ylamine;Eur. J. Med. Chem. Chim. Ther., 15: 317-322 (1980).
Gonzalez, III Jesus E.
Martinborough Esther
Neubert Timothy D.
Termin Andreas P.
Wang Jian
Badia Michael C.
Jaisle Cecilia M
Vertex Pharmaceuticals Inc.
Wilson James O
LandOfFree
Compositions useful as inhibitors of voltage-gated ion channels does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions useful as inhibitors of voltage-gated ion channels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions useful as inhibitors of voltage-gated ion channels will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2670720